TrialBritish journal of haematology2011

Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report.

Bruce Shiramizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.